Skip to main content
Fig. 5 | BMC Rheumatology

Fig. 5

From: Treatment approaches for idiopathic retroperitoneal fibrosis: a systematic review with meta-analysis

Fig. 5

Forest plot for the outcome “relapse rate”. *Follow-up months as a median; **Follow-up months includes follow-up from patients treated with a different treatment method; *** Relapse rate at last follow-up after treatment discontinuation. Relapse rate at primary endpoint after 8 months was 6% for the prednisone group and 39% for the tamoxifen group; Trt treatment, n patient number, AZA Azathioprine, CST Corticosteroids, CYP Cyclophosphamide, MMF Mycophenolate Mofetil, TMX Tamoxifen, UL Ureterolysis

Back to article page